These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 9799009)

  • 1. Tissue factor and tissue factor pathway inhibitor in acute and chronic renal failure.
    Malyszko J; Malyszko JS; Mysliwiec M
    Thromb Haemost; 1998 Oct; 80(4):722-4. PubMed ID: 9799009
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo effect of Chianti red wine on tissue factor, tissue factor pathway inhibitor and homocysteine levels.
    Marcucci R; Gori AM; Bertuccioli M; Gensini GF; Abbate R
    Thromb Haemost; 2005 Sep; 94(3):689-90. PubMed ID: 16268496
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes of tissue factor pathway in essential hypertension].
    Zhang WR; Sun M; Zhou HY; Wu S; He J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):347-8. PubMed ID: 16136978
    [No Abstract]   [Full Text] [Related]  

  • 4. [Levels of plasma TF and TFPI activities in patients with acute leukemia].
    Zhu Y; Xie ZX; He XF; Han JZ; Li JC; He SL
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):401-2, 405. PubMed ID: 12206017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.
    Naumnik B; Borawski J; Chyczewski L; Pawlak K; Mysliwiec M
    Nephrol Dial Transplant; 2006 Dec; 21(12):3450-7. PubMed ID: 16982632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes of TF and TFPI activities in patients with hypertension or coronary atherosclerotic heart disease].
    Xiao Z; Wang W; Han J; He X; Li J
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):251-2, 255. PubMed ID: 12016797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue factor and tissue factor pathway inhibitor levels in coronary artery disease: correlation with the severity of atheromatosis.
    Lima LM; Sousa MO; Dusse LM; Lasmar MC; das Graças Carvalho M; Lwaleed BA
    Thromb Res; 2007; 121(2):283-7. PubMed ID: 17582470
    [No Abstract]   [Full Text] [Related]  

  • 8. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
    Gosk-Bierska I; Wysokin Ski W; Karnicki K; Adamiec R
    Int Angiol; 2008 Aug; 27(4):296-301. PubMed ID: 18677291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue factor pathway inhibitor relates to fibrin degradation in patients with acute deep venous thrombosis.
    Sidelmann JJ; Bladbjerg EM; Gram J; Münster AM; Jespersen J
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):405-9. PubMed ID: 18600090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
    Lizakowski S; Zdrojewski Z; Jagodzinski P; Rutkowski B
    Scand J Urol Nephrol; 2007; 41(3):237-42. PubMed ID: 17469034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2007; 120(6):871-6. PubMed ID: 17331567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercoagulability is independently associated with kynurenine pathway activation in dialysed uraemic patients.
    Pawlak K; Mysliwiec M; Pawlak D
    Thromb Haemost; 2009 Jul; 102(1):49-55. PubMed ID: 19572067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration.
    Gori AM; Pepe G; Attanasio M; Falciani M; Abbate R; Prisco D; Fedi S; Giusti B; Brunelli T; Giusti B; Brunelli T; Comeglio P; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1999 Apr; 81(4):589-93. PubMed ID: 10235445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tissue factor and tissue factor pathway inhibitor during specific bronchial challenge in allergic asthma patients].
    Kemona-Chetnik I; Bodzenta-Lukaszyk A; Kucharewicz I; Rogalewska AM
    Przegl Lek; 2005; 62(2):98-101. PubMed ID: 16095153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between tissue factor, its pathway inhibitor and oxidative stress in peritoneal dialysis patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):467-71. PubMed ID: 17581322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion protein in patients with renal failure.
    Starke R; Mackie I; Drummond O; MacGregor I; Harrison P; Machin S
    Transfus Med; 2006 Jun; 16(3):165-8. PubMed ID: 16764594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria.
    Asero R; Tedeschi A; Coppola R; Griffini S; Paparella P; Riboldi P; Marzano AV; Fanoni D; Cugno M
    J Allergy Clin Immunol; 2007 Mar; 119(3):705-10. PubMed ID: 17204316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tissue factor (TF) and inhibitor (TFPI) concentrations in patients with urinary tract tumors and haematological malignancies].
    Radziwon P; Schenk JF; Mazgajska K; Boczkowska-Radziwon B; Galar M; Kłoczko J; Wojtukiewicz MZ
    Pol Merkur Lekarski; 2002 Oct; 13(76):308-11. PubMed ID: 12557438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
    Saigo M; Abe S; Ogawa M; Yamashita T; Biro S; Minagoe S; Maruyama I; Tei C
    Thromb Haemost; 2001 Nov; 86(5):1197-203. PubMed ID: 11816707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of plasma tissue factor pathway and urokinase-type plasminogen activator system in cancer patients.
    Zhao W; Wang X; Qu B; Huang X; Wang H
    Chin Med J (Engl); 2002 May; 115(5):702-4. PubMed ID: 12133538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.